Overview

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis

Status:
Completed

Trial end date:
2014-04-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and the safety of Risedronate, cholecalciferol combination tablet in patients with Osteoporosis.

Phase:

Phase 4

Details

Lead Sponsor:

Hanlim Pharm. Co., Ltd.

Treatments:

Cholecalciferol
Etidronic Acid
Risedronate Sodium
Risedronic Acid